Protocol · PharmD · Wyoming
Practice Protocol for Pharmacists in Wyoming
Required. Wyoming law names the instrument a Collaborative Practice Agreement, and the clinical protocol is the content that instrument carries. Below: the board that governs it, what it must contain, and the terms it has to carry.
Represents Wyoming's Collaborative Pharmaceutical Care agreement tier (W.S. § 33-24), not ordinary pharmacist licensure — base dispensing and standalone statutory authorities (hormonal contraceptives under § 33-24-159, immunizations under § 33-24-157) need no physician-specific CPA and are out of scope here. No board-certification requirement or numeric per-prescriber cap was found for the general collaborative-care CPA.
What a Wyoming Collaborative Practice Agreement must contain
Governed by the Wyoming State Board of Pharmacy. Each numbered item is a statutory requirement the Collaborative Practice Agreement must satisfy.
The Pharmacist shall not conduct medication therapy management ("MTM") for a patient under this Agreement unless the Physician and the Pharmacist have first executed a written collaborative practice agreement, forwarded five (5) signed copies to the Wyoming State Board of Pharmacy, and received written notice of the Board's approval; the Pharmacist shall not practice under the collaborative practice agreement, or any later revision to it, until so notified.
The Physician and Pharmacist must each be currently licensed by their respective Wyoming boards and in active practice in this State for the collaborative practice agreement to remain valid.
- The Collaborative Practice Agreement also carries 2 scope, 1 education, 1 registration and 1 authority clauses, authored in the document itself.
Statutes and rules these clauses cite
- Wyoming Pharmacy Act Rules and Regulations, Chapter 20, Collaborative Practice Regulations (promulgated under Wyo. Stat. Ann. §§ 33-24-101 through -301)regulation
Wyoming Board of Pharmacy rule (filed with the Wyoming Legislature's rule-tracking system) setting the mandatory content, Board-approval process, and scope limits for a pharmacist collaborative practice agreement conducting medication therapy management.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the Collaborative Practice Agreement has to carry, from Wyoming's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · no controlled-substance authority
No affirmative statutory grant of controlled-substance prescribing authority under a general Wyoming CPA was located — coded as not allowed pending confirmation; the hormonal-contraceptive and immunization authorities are separate, narrower statutory grants, not general controlled-substance authority.
Written agreement
Required
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — No pharmacist-ownership requirement identified in Wyoming statute; distinct from the CPA-based scope-of-practice question above
Sources for the supervision rules (2)
About Wyoming's rules
Wyoming is a full-independence state for ALL FOUR APRN roles (NP, CRNA, CNM, CNS) under the APRN Consensus Model — no supervision/collaboration agreement required. PAs are separate: permanent physician supervision under W.S. 33-26, capped at 3 PAs per physician absent Board-approved good cause (W.S. 33-26-504) — one of the few explicit numeric PA ratio caps on file.
Other clinicians in Wyoming: see the state overview.